Skip Nav Destination
Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy
Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials
Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes
Calcitonin receptor‐like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML
The impact of pulmonary function in patients undergoing autologous stem cell transplantation
Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease
Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI
DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia
Issue Archive
Table of Contents
STIMULUS REPORT
SYSTEMATIC REVIEW
CLINICAL TRIALS AND OBSERVATIONS
Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy
Clinical Trials & Observations
Fabio Efficace,Uwe Platzbecker,Massimo Breccia,Francesco Cottone,Paola Carluccio,Prassede Salutari,Eros Di Bona,Erika Borlenghi,Francesco Autore,Luciano Levato,Olimpia Finizio,Valentina Mancini,Stefano D’Ardia,Richard F. Schlenk,Lorella Melillo,Monica Fumagalli,Walter Fiedler,Germana Beltrami,Nicola Stefano Fracchiolla,Massimo Bernardi,Paola Fazi,Ombretta Annibali,Karin Mayer,Maria Teresa Voso,Marco Vignetti
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy
Clinical Trials & Observations
Andrew Johnsrud,Juliana Craig,John Baird,Jay Spiegel,Lori Muffly,James Zehnder,John Tamaresis,Robert Negrin,Laura Johnston,Sally Arai,Judith Shizuru,Robert Lowsky,Everett Meyer,Wen-Kai Weng,Parveen Shiraz,Andrew Rezvani,Theresa Latchford,Crystal Mackall,David Miklos,Matthew Frank,Surbhi Sidana
Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial
Clinical Trials & Observations
Umberto Ricardi,Mario Levis,Andrea Evangelista,Daniela Maria Gioia,Gian Mauro Sacchetti,Manuel Gotti,Alessandro Re,Michela Buglione,Vincenzo Pavone,Antonio Nardella,Luca Nassi,Manuela Zanni,Paola Franzone,Giovanni Piero Frezza,Alessandro Pulsoni,Lavinia Grapulin,Armando Santoro,Luigi Rigacci,Gabriele Simontacchi,Monica Tani,Francesco Zaja,Elisabetta Abruzzese,Barbara Botto,Vittorio Ruggero Zilioli,Delia Rota-Scalabrini,Roberto Freilone,Giovannino Ciccone,Andrea Riccardo Filippi,Pier Luigi Zinzani
HEALTH SERVICES AND OUTCOMES
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials
Clinical Trials & Observations
HEMATOPOIESIS AND STEM CELLS
R4 RGS proteins suppress engraftment of human hematopoietic stem/progenitor cells by modulating SDF-1/CXCR4 signaling
Kathy Yuen Yee Chan,Chi Zhang,Yorky Tsin Sik Wong,Xiao-Bing Zhang,Chi Chiu Wang,Wing Hei Ng,Siu Ping Fok,Patrick Ming Kuen Tang,Wei Kang,Bo Feng,Ellen Ngar Yun Poon,King Yiu Lee,Cheuk Kwong Lee,Chun Chen,Tak Yeung Leung,Margaret Heung Ling Ng,Ka Fai To,Han Wang,Hugh Simon Lam,Pak Cheung Ng,Patrick Man Pan Yuen,Karen Li,Alex Wing Kwan Leung,Chi Kong Li,Kam Tong Leung
IMMUNOBIOLOGY AND IMMUNOTHERAPY
LYMPHOID NEOPLASIA
Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study
Clinical Trials & Observations
Maria Gavriatopoulou,Evangelos Terpos,Ioannis Ntanasis-Stathopoulos,Alexandros Briasoulis,Sentiljana Gumeni,Panagiotis Malandrakis,Despina Fotiou,Magdalini Migkou,Foteini Theodorakakou,Evangelos Eleutherakis-Papaiakovou,Nikolaos Kanellias,Efstathios Kastritis,Ioannis P. Trougakos,Meletios A. Dimopoulos
MYELOID NEOPLASIA
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes
Clinical Trials & Observations
Nathan Radakovich,Manja Meggendorfer,Luca Malcovati,C. Beau Hilton,Mikkael A. Sekeres,Jacob Shreve,Yazan Rouphail,Wencke Walter,Stephan Hutter,Anna Galli,Sara Pozzi,Chiara Elena,Eric Padron,Michael R. Savona,Aaron T. Gerds,Sudipto Mukherjee,Yasunobu Nagata,Rami S. Komrokji,Babal K. Jha,Claudia Haferlach,Jaroslaw P. Maciejewski,Torsten Haferlach,Aziz Nazha
Calcitonin receptor‐like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML
Clinical Trials & Observations
Linus Angenendt,Marius Wöste,Jan-Henrik Mikesch,Maria Francisca Arteaga,Adrian Angenendt,Sarah Sandmann,Wolfgang E. Berdel,Georg Lenz,Martin Dugas,Soheil Meshinchi,Christoph Schliemann,Claudia Rössig
TRANSPLANTATION
The impact of pulmonary function in patients undergoing autologous stem cell transplantation
Clinical Trials & Observations
Jesús Duque-Afonso,Sophie Ewald,Gabriele Ihorst,Miguel Waterhouse,Tim Struessmann,Robert Zeiser,Ralph Wäsch,Hartmut Bertz,Joachim Müller-Quernheim,Justus Duyster,Jürgen Finke,Reinhard Marks,Monika Engelhardt
Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease
Clinical Trials & Observations
Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI
Clinical Trials & Observations
Christian R. Schultze-Florey,Leonie Kuhlmann,Solaiman Raha,Joana Barros-Martins,Ivan Odak,Likai Tan,Yankai Xiao,Sarina Ravens,Lothar Hambach,Letizia Venturini,Michael Stadler,Matthias Eder,Felicitas Thol,Michael Heuser,Reinhold Förster,Arnold Ganser,Immo Prinz,Christian Koenecke
RESEARCH LETTER
DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia
Clinical Trials & Observations
David G. J. Cucchi,Christian M. Vonk,Melissa Rijken,François G. Kavelaars,Pauline A. Merle,Elvira Verhoef,Bianca Venniker-Punt,Zinia J. Kwidama,Patrycja Gradowska,Bob Löwenberg,Jeroen J. W. M. Janssen,Jacqueline Cloos,Peter J. M. Valk
Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting
Maria A. V. Marzolini,Varun Mehra,Kirsty J. Thomson,Eleni Tholouli,Adrian J. C. Bloor,Anne Parker,Richard Lovell,Kim Orchard,Amy Publicover,Emma Nicholson,John A. Snowden,Jennifer Byrne,Anjum Khan,Maria H. Gilleece,Gerardo Errico,Sara Lozano,Erin Hurst,Nick Duncan,Jennifer Pirrie,Philip Crea,Ben Carpenter,Antonio Pagliuca,Karl S. Peggs
COMMENTARY
-
Cover Image
Cover Image
Fluorescence microscopy of human lymphoid tissue (tonsil) stained for macrophages (CD68, green) and for hematopoietic lineage-restricted antigen (CD45, red). Lack of CD45 expression by tingible body macrophages suggests a tissue-resident origin for these cells, while tumor-associated macrophages from patients with diffuse large B-cell lymphoma are from hematopoietic origin and recruited through tumor-derived CCL5. See the article by Manfroi et al.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals